Universal Influenza Vaccine Technology Landscape Now Available
The Universal Influenza Vaccine Technology Landscape is a database of novel vaccine candidates designed to provide broader and more durable immunity against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. The landscape encompasses a wide range of investigational technologies that have reached clinical or late preclinical stages of development; some are under active investigation in funded research programs, while others are not in active development. As a research tool, the landscape is intended to summarize available data on influenza vaccine candidates in development to help coordinate efforts across research groups and stimulate informed investment. The landscape is publicly accessible via the CIDRAP website and will be continuously updated as new developments emerge.
The landscape project is funded by the Global Funders Consortium for Universal Influenza Vaccine Development and is guided by an advisory working group of subject-matter experts from the World Health Organization, the US National Institutes of Health, the European Commission, the US Biomedical Advanced Research and Development Authority, PATH, and the Global Funders Consortium for Universal Influenza Vaccine Development. As an academic unit operating independently within the University of Minnesota, CIDRAP serves as a neutral platform for collecting and analyzing influenza vaccine data. CIDRAP is conducting this project in parallel with the Influenza Vaccines R&D Roadmap initiative, funded by Wellcome Trust.